Inferra AI / Company / NEOG
Neogen Corp
NEOG · Health Care
Last earnings Oct 6, 2026
Key results
Revenuequarter
$225.3 million
revenue of $225.3 million representing growth of (0.1%) and Core Growth 1 of 4.3%
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
revenue of $870.4 million with growth of (2.7%) and Core Growth 1 of 1.9% •
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
revenue grew 7% sequentially due to resolution of the majority of supply challenges •
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Free cash flowquarter
$26.2 million
free cash flow of $26.2 million •
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
• Food Safety segment revenue was $166.8 million in the fourth quarter, increasing 3.1% relative to the fourth quarter of fiscal year 2025.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Core Food Safety revenuequarter
5.8%
Core Food Safety revenue growth increased 5.8% on a year-over-year basis, the highest rate since the period immediately following the acquisition of the 3M Food Safety business in FY23.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
• Animal Safety segment revenue was $58.5 million in the fourth quarter, representing growth of (8.2%) relative to the fourth quarter of fiscal year 2025.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Core Animal Safety revenuequarter
0.5%
Core Animal Safety revenue increased 0.5% on a year-over-year basis.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
EPSquarter
$612.2 million
diluted share, compared to a net loss of $612.2 million, or $(2.82)
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
AI analysis
Q4 FY2026 · reported Jul 30, 2026
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Headline figures
| Metric | Q4 FY2026 | Prior qtr | Year ago |
|---|---|---|---|
| Revenue | $225.3 million | — | — |
| Free cash flow | $26.2 million | — | — |
| Core Food Safety revenue | 5.8% | — | — |
| Core Animal Safety revenue | 0.5% | — | — |
| EPS | $612.2 million | — | — |
Guidance · company-stated
Direction: raised
No guidance located in the held release
“7% • Company on track to manufacture saleable Petrifilm product and begin planned multi-quarter manufacturing transition in November 2026; first single kit unit (SKU) fully validated • Raising fiscal year 2027 financial guidance for revenue and Adjusted EBITDA 1 1 Non-GAAP financial measures; see explanations and reconciliations that follow LANSING, October 6, 2026 – Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the first quarter of fiscal year 2027.”
Cash flow & capex
Capital allocation
The Company plans to use the proceeds from the transaction primarily for debt reduction.
Net debt is a non-GAAP measure calculated as total debt (current and non-current) less cash and cash equivalents.
Event summary
Neogen Corp — Earnings release (2026-07-30)
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
No guidance located in the held release
Capital allocation
The Company plans to use the proceeds from the transaction primarily for debt reduction.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Net debt is a non-GAAP measure calculated as total debt (current and non-current) less cash and cash equivalents.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Net debt-to-Adjusted EBITDA is a non-GAAP ratio that uses net debt as the numerator and Adjusted EBITDA as the denominator.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
The Company uses net debt-to-Adjusted EBITDA to evaluate its leverage position and the expected impact of debt repayment and deleveraging initiatives.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
The Company’s senior credit facility contains financial covenants that utilize leverage ratios calculated using measures substantially similar to Adjusted EBITDA.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
As of May 31, 2026, total debt was $793.7 million, cash and cash equivalents were $185.5 million, resulting in net debt of $608.2 million.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Strategy & priorities
“We ended fiscal year 2026 with significant momentum and have a number of initiatives underway to further enhance our commercial efforts and the way we approach customers and our core markets.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Our entire organization is focused on disciplined execution and sustaining the operational momentum that we have seen in the business throughout fiscal year 2026.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Adjusted EBITDA margins benefited from the impact of the Company's first quarter cost saving initiatives and improvements in gross margins.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
• Neogen is supporting efforts to counter the New World Screwworm (NWS) expansion in the United States.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
• The Company is in the process of launching its new global go-to-market strategy and enterprise-wide solutions-based selling model.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Risks & headwinds
On a sequential basis, Animal Safety revenue increased by over 7% as the Company resolved the majority of the supply related challenges, which had resulted in product shortages.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
These “forward-looking statements” are management’s present expectations of future events as of the date hereof and are subject to a number of known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially and adversely from those anticipated.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
(9) Includes costs primarily associated with shareholder litigation and other legal expenses and product recall expenses.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
(4) Includes costs primarily associated with shareholder litigation and other legal expenses and product recall expenses.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
(8) Includes costs primarily associated with shareholder litigation and other legal expenses and product recall expenses.
SEC original ↗Neogen Corp — Earnings release (8-K exhibit)EX-99Jul 30, 2026
Legal Proceedings 26 Item 1A.
SEC original ↗Neogen Corp — 10-Q Quarterly report10-QOct 7, 2026
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
30 documents- Q3 2026
- 8-KNEOG
Oct 7, 2026
- 10-QNEOG
Oct 7, 2026
- 8-KNEOG
Oct 6, 2026
- Q2 2026
- 8-KNEOG
Aug 7, 2026
- 8-KNEOG
Jul 30, 2026
- 10-KNEOG
Jul 30, 2026
- Q1 2026
- 8-KNEOG
Apr 20, 2026
- 8-KNEOG
Apr 9, 2026
- 10-QNEOG
Apr 9, 2026
- Q4 2025
- 8-KNEOG
Mar 30, 2026
- 8-KNEOG
Jan 8, 2026
- 10-QNEOG
Jan 8, 2026
- Q3 2025
- 8-KNEOG
Oct 30, 2025
- 8-K/ANEOG
Oct 28, 2025
- 8-KNEOG
Oct 27, 2025
- 8-K/ANEOG
Oct 27, 2025
- 8-KNEOG
Oct 9, 2025
- 10-QNEOG
Oct 9, 2025
- Q2 2025
- 8-KNEOG
Sep 15, 2025
- 8-KNEOG
Aug 21, 2025
- 8-KNEOG
Aug 14, 2025
- 10-KNEOG
Jul 30, 2025
- 8-KNEOG
Jul 29, 2025
- 8-KNEOG
Jul 24, 2025
- Q1 2025
- 8-KNEOG
Jun 4, 2025
- 8-KNEOG
May 14, 2025
- 8-KNEOG
May 13, 2025
- 8-KNEOG
Apr 22, 2025
- 8-KNEOG
Apr 9, 2025
- 10-QNEOG
Apr 9, 2025
Earnings releases
6 documentsPresentations
0 documentsNo presentations for Neogen Corp are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Neogen Corp are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.